12th European AIDS Conference / EACS
Webcasted Presentation

Search’n Build™

Time to virologic response (TVR) is not associated with response durability in treatment-naïve patients receiving efavirenz (EFV)-based highly active antiretroviral therapy (HAART)

Ramin Ebrahimi
Ramin Ebrahimi
United States of America  
Disclosure : Employee of Gilead Sciences Inc.
[More] [Less]
2 slide(s) – 00:04:15 – English – 2009-11-13
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.